Expected earnings - Neumora Therapeutics Inc.
Source: US Earnings Reports
Neumora Therapeutics Inc. (NMRA) is expected to report $-0.34 for Q4 2025
Neumora Therapeutics Inc.
NASDAQ: NMRA
NMRA Trading
-0.67% G/L:
$2.975 Last:
548,324 Volume:
$2.96 Open:
NMRA Latest News
February 04, 2026 07:00:00 am
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
NMRA Stock Data
$499,596,451
52,800,160
10.86%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
